Skip to main content

Table 1 Details of patients who underwent reconstruction with inactivated autograft treated with alcohol

From: The long-term outcomes following the use of inactivated autograft in the treatment of primary malignant musculoskeletal tumor

Case Gender and age(Y) Location Stagea Histology Length, cm Resection MSTSS score ,% Outcomes Follow-up (months)
1 M/12 DF IIB OSA 15 IA 81 Death 29
2 M/16 PT IIB OSA 18 IA 92 DF 61
3 F/21 PT IIB CHOS 21 IA 95 DF 70
4 M/12 DF IIB OSA 17 IA 81 DF 78
5 F/13 PT IIB OSA 23 IC 73 DF 69
6 F/17 PT IIB OSA 16 IA 85 DF 73
7 M/2O PF IIB SSA 25 IA 69 Death 23
8 M/16 DF IB OSA 18 IC 67 DF 90
9 M/32 PT IIB CHOS 16 IA 98 DF 84
10 F/11 PH IB OSA 27 IA 87 DF 96
11 F/15 SH IIB 0SA 21 IC 89 Death 40
12 M/19 DF IIB SSA 15 EA 72 Death 43
13 M/14 DF IIB EWS 18 IC 78 Death 48
14 M/23 PT IIB CHOS 19 IA 91 DF 72
15 M/17 PF IIB OSA 31 IA 76 DF 68
16 F/13 DF IIB OSA 22 EA 80 Death 55
17 F/19 PT IB IGTB 19 IC 77 DF 88
18 M/39 PT IB CHOS 17 IA 96 Death 56
19 M/26 DF IIB CHOS 22 IA 72 DF 60
20 M/21 PT IIB MCHOS 23 IA 94 DF 62
21 F/15 DF IIB OSA 28 IA 85 Death 36
22 F/14 PF IB IGTB 24 IA 70 Death 29
23 M/15 PT IIB OSA 16 IC 87 DF 70
24 M/26 DF IIB MCHOS 17 IA 85 Death 18
25 F/18 PT IIB OSA 19 IC 78 DF 79
26 M/2O DF IIB FSA 18 IA 67 Death 28
27 F/13 DF IIB EWS 30 IA 54 Death 41
28 F/16 PT IB OSA 21 IA 86 Death 38
29 M/25 PT IIB CHOS 25 IA 74 DF 64
30 M/17 PH IIB OSA 17 EA 47 Death 28
31 F/12 DF IB OSA 19 IA 86 DF 65
32 M/15 PT IIB IGTB 23 IA 95 DF 96
33 M/19 DF IIB FSA 29 IA 82 Death 29
34 F/22 PT IIB MCHOS 22 IA 83 Death 38
35 F/13 DF IB OSA 25 IC 70 DF 80
36 M/18 PT IIB OSA 18 EA 93 Death 34
37 F/45 DF IIB CHOS 15 IA 85 DF 70
38 F/16 PT IIB 0SA 19 IA 67 DF 66
39 M/19 DF IIB SSA 21 IA 94 Death 53
40 M/13 PT IIB MFCT 29 IA 73 Death 48
41 M/21 DF IB CHOS 18 IC 49 Death 36
42 M/14 PH IIB OSA 16 IA 85 Death 52
43 M/19 DF IIB OSA 14 IA 79 DF 78
44 M/2O PT IB MCHOS 19 IA 70 Death 30
45 F/12 DF IIB OSA 21 IA 81 Death 42
46 F/17 PT IIB OSA 29 IA 58 Death 23
47 M/15 PT IIB OSA 31 IA 84 DF 88
48 M/21 DF IB MCHOS 17 IA 78 Death 55
49 F/16 PH IIB OSA 19 IC 59 Death 28
50 F/19 PT IIB SSA 21 IA 80 Death 34
51 F/11 DF IIB OSA 27 IA 71 Death 33
52 F/17 PT IIB OSA 22 IA 97 DF 82
53 M/38 PT IB CHOS 25 IA 71 Death 46
54 M/12 DF IIB OSA 17 IC 93 Death 58
55 M/15 PT IIB MFCT 19 IA 48 Death 19
56 F/11 DF IIB OSA 26 IA 75 DF 72
57 F/24 PT IB CHOS 19 IC 79 Death 46
58 M/13 PT IIB SSA 17 IA 83 Death 55
  1. DF distal femur, PF proximal femur, PH proximal humerus, PT proximal tibia, SH shaft humerus, OSA osteosarcoma, CHOS chondrosarcoma, MCHOS mucus chondrosarcoma, FSA fibrosarcoma, EWS Ewing’s sarcoma, IGTB invasive giant cell tumor of bone, MFCT malignant fibrous cell tumors, SSA synovial sarcoma, EA extra-articular, IA intra-articular, IC intercalary, DF disease free
  2. aEnneking surgical stage